Diagnostic care health applications, enabled by artificial intelligence (AI), have become more widely available directly to consumers, including on mobile devices. However, consumers have been slow to adopt the use of such tools as they tend to trust human health care providers more than their AI analog. Lack of appreciation of the patient’s unique needs and the ambiguity surrounding accountability for mistakes made by AI, are just a few of the reasons that the consumer trust lags. In a recent Harvard Business Review article co-authored by Chiara Longoni, assistant professor of marketing, Carey Morewedge, professor of marketing, and their colleague Romain Cadario, assistant professor of marketing at Erasmus University, they grapple with this issue and discuss potential interventions.
Consumer adoption of medical AI has as much to do with their negative perceptions of AI care providers as with their unrealistically positive views of human care providers. Consumers are reluctant to rely on AI care providers because they do not believe they understand or objectively understand how AI makes medical decisions; they view its decision-making as a black box.Chiara Longoni
Assistant Professor of Marketing
Professor of Marketing
Understanding consumer resistance to AI is a critical topic for policymakers. For many health policy experts, the use of innovative health services and technology are a means to improving the health care system.
- The Great Resignation: Historical Data and a Deeper Analysis Show It’s Not as Great as Screaming Headlines Suggest
- The Wisdom of the Crowd and Prediction Markets
- Nature Human Behavior: Understanding, Explaining, and Utilizing Medical Artificial Intelligence
- Boston Globe: The Next Generation of Business Leaders is Entering a Changed World of Work. Will Their Education Prepare Them?
- ZDNet: Amazing Things Happen When IT and Business Leaders Collaborate
- USA Today: How Easy Will Health Insurers Make it to Get Free, At-Home COVID-19 Tests?
- Harvard Business Review: Digital Transformation Changes How Companies Create Value
- Expert Take: Regulating Prescription Drug Prices While Increasing Innovation
- Forbes: OSHA Launches Investigation Into Amazon Warehouse Hit By Tornado
- StrategicCFO360: First Read: Your Digitalization Agenda